跳至主要内容
临床试验/NCT00397358
NCT00397358撤回4 期

Open-label Study to Evaluate the Effects of Once Daily Extraneal (7.5% Icodextrin) Peritoneal Dialysis Solution on Triglyceride Levels in Peritoneal Dialysis Patients

Vantive Health LLC6 个研究点 分布在 1 个国家开始时间: 2006年11月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
撤回
试验地点
6
主要终点
Change from baseline in fasting triglyceride levels.

研究概览

简要总结

This is a Phase IV study evaluating triglyceride levels in peritoneal dialysis patients.

详细描述

This prospective, open label, multi-center study evaluates the use of 7.5% icodextrin used in the long-dwell exchange in peritoneal dialysis patients with elevated triglyceride levels. Fasting triglyceride levels will be measured during the study.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • written informed consent
  • CAPD/APD on dialysis for at least 3 months
  • Elevated fasting triglyceride levels

排除标准

  • enrolled in another study requiring IRB approval
  • allergy to starch-based polymers
  • glycogen storage disease
  • maltose or isomaltose intolerance
  • active alcohol/substance abuse
  • Pregnant or nursing
  • received an investigational drug within 30 days of screening

结局指标

主要结局

Change from baseline in fasting triglyceride levels.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验